Patent №
US 10,273,544
Granted
2019-04-30
Filed 2012
Owner
DANA-FARBER CANCER INSTITUTE, INC.
Lab
—
AI components
1
evo
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
13574001
The disclosure provides materials and methods related to using biomarkers for prediction of duration of response to prostate cancer treatment and for treating prostate cancer.
AI classification
Evolutionary computation0.54
Natural language0.06
Machine learning0.00
Planning0.00
AI hardware0.00
Knowledge representation0.00
Speech0.00
Vision0.00
Ownership
DANA-FARBER CANCER INSTITUTE, INC.
assignment · 291070061
Assignors
KANTOFF, PHILIP W., YANG, MING, LEE, GWO-SHU MARY, SUN, TONG, XIE, WANLING
On an employer assignment, the assignors are typically the inventors.
From the same owner
SYSTEM AND METHOD OF USING MACHINE LEARNING FOR EXTRACTION OF SYMPTOMS FROM ELECTRONIC HEALTH RECORDSUS 11,915,828 · 2024COMPOSITIONS AND METHODS FOR PREDICTING RESPONSE AND RESISTANCE TO CDK4/6 INHIBITIONUS 11,845,992 · 2023DYNAMIC BH3 PROFILINGUS 11,815,508 · 2023ACRYLAMIDE COPOLYMERIZATION FOR SEQUESTRATION AND PRODUCTION OF SINGLE-STRANDED NUCLEIC ACIDUS 11,767,523 · 2023POLYMORPHIC GENE TYPING AND SOMATIC CHANGE DETECTION USING SEQUENCING DATAUS 11,725,237 · 2023EXTENDED FIELD-OF-VIEW X-RAY IMAGING USING MULTIPLE X-RAY SOURCES AND ONE OR MORE LATERALLY OFFSET X-RAY DETECTORSUS 11,666,293 · 2023METHODS AND COMPOSITIONS FOR REDUCING IMMUNOSUPRESSION BY TUMOR CELLSUS 11,597,934 · 2023METHODS AND COMPOSITIONS FOR STUDYING CELL EVOLUTIONUS 11,547,614 · 2023